Cediranib Shows Promise for Differentiated Thyroid Cancer
TUESDAY, Sept. 19, 2023 (HealthDay News) — The multitargeted tyrosine kinase inhibitor (TKI) of the vascular endothelial growth factor receptor (VEGFR) pathway, cediranib, shows promise for differentiated thyroid cancer (DTC), but the addition of len…
Learn MoreOptimized AI Strategy for Thyroid Nodules Benefits Some Radiologists
MONDAY, May 22, 2023 (HealthDay News) — An optimized artificial intelligence (AI) strategy can reduce diagnostic time-based costs for senior radiologists, while the traditional all-AI strategy seems more beneficial for junior radiologists, according …
Learn MoreParathyroidectomy Has No Effect on Kidney Function in Older Adults
WEDNESDAY, April 12, 2023 (HealthDay News) — For adults with primary hyperparathyroidism (PHPT), parathyroidectomy has no effect on long-term kidney function versus nonoperative management, according to a study published online April 11 in the Annals…
Learn MoreMany Thyroid Cancer Survivors Cite Inadequate Pretreatment Understanding
THURSDAY, Dec. 29, 2022 (HealthDay News) — A considerable proportion of survivors of thyroid cancer report inadequate pretreatment understanding, according to a study published online Dec. 29 in JAMA Otolaryngology-Head & Neck Surgery.Amanda Silver K…
Learn MoreClinical Report Addresses Screening, Management of Congenital Hypothyroidism
TUESDAY, Dec. 20, 2022 (HealthDay News) — Newborn screening (NBS) and management of congenital hypothyroidism is addressed in a clinical report published online Dec. 19 in Pediatrics.Noting that prompt diagnosis of congenital hypothyroidism by NBS, l…
Learn MoreLifestyle May Counter Genetic Risk for Thyroid Cancer
FRIDAY, Dec. 16, 2022 (HealthDay News) — Genetic and lifestyle factors are independently associated with incident thyroid cancer, according to a study published online Dec. 12 in JAMA Network Open.Xiuming Feng, from Guangxi Medical University in Nann…
Learn MoreActive Surveillance Feasible for Low-Risk Thyroid Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Center in Los An…
Learn MoreLas PFAS, unos ‘compuestos permanentes’, cuestan miles de millones a EE. UU.
MIÉRCOLES, 27 de julio de 2022 (HealthDay News) — Se conocen como “compuestos permanentes” porque persisten en el cuerpo humano, y pueden contribuir al riesgo de muchas cosas, desde el cáncer hasta la obesidad infantil. Ahora, una nueva investigación…
Learn MorePFAS ‘Forever Chemicals’ Cost the U.S. Billions
WEDNESDAY, July 27, 2022 (HealthDay News) — They are called “forever chemicals” because they linger in the human body and can contribute to the risk of everything from cancer to childhood obesity. Now, new research on per- and polyfluoroalkyl substan…
Learn MoreThyroid Trouble May Raise Dementia Risks
MONDAY, July 18, 2022 (HealthDay News) — Millions of older adults try to manage an underactive thyroid gland with daily medication, but a new study suggests they may still be vulnerable to developing dementia as they age.Researchers found that among …
Learn More